Cargando…
Differences in PD-L1 Expression between oral and oropharyngeal squamous cell carcinoma
Treatment of metastasized or recurrent oral (OSCC) and oropharyngeal (OPSCC) squamous cell carcinoma remains challenging. Targeted antibody-based therapy inter alia for PD-1 / PD-L1 axis shows promising results, but whether PD-L1 expression varies between the subentities remains unclear. The express...
Autores principales: | Blatt, Sebastian, Krüger, Maximilian, Rump, Constantin, Zimmer, Stefanie, Sagheb, Keyvan, Künzel, Julian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140279/ https://www.ncbi.nlm.nih.gov/pubmed/35622885 http://dx.doi.org/10.1371/journal.pone.0269136 |
Ejemplares similares
-
Tumor Recurrence and Follow-Up Intervals in Oral Squamous Cell Carcinoma
por: Blatt, Sebastian, et al.
Publicado: (2022) -
Oral Squamous Cell Carcinomas Developing from Oral Lichen Planus: A 5–21 year Retrospective Study
por: Sagheb, Kawe, et al.
Publicado: (2022) -
Clinical efficacy of an antibody-based detection system for human papilloma virus infection in oral squamous cell carcinoma
por: Blatt, Sebastian, et al.
Publicado: (2020) -
Significance of Extranodal Extension in Surgically Treated HPV-Positive Oropharyngeal Carcinomas
por: Beltz, Anna, et al.
Publicado: (2020) -
Growth Factor Receptor Expression in Oropharyngeal Squamous Cell Cancer: Her1–4 and c-Met in Conjunction with the Clinical Features and Human Papillomavirus (p16) Status
por: Deuss, Eric, et al.
Publicado: (2020)